Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Novo Nordisk A/S Class B (0QIU)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
893.05 +18.90    +2.16%
01:35:59 - Closed. Currency in DKK ( Disclaimer )
  • Volume: 143,394
  • Bid/Ask: 855.50 / 890.40
  • Day's Range: 878.10 - 893.70
Type:  Equity
Market:  United Kingdom
ISIN:  DK0060534915 
SEDOL:  BP6KMR9
Novo Nordisk B 893.05 +18.90 +2.16%

0QIU Cash Flow Statement

 
Featured here, the Cash Flow Statement for Novo Nordisk A/S Class B, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line 21963 22478 19428 19814
Cash From Operating Activities 9551 40966 28577 29814
Depreciation/Depletion 655 2525 2177 1719
Amortization - - - -
Deferred Taxes -4011 - - -
Non-Cash Items -3597 4294 10987 18497
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 11071 3479 4668 6679
Cash Interest Paid 140 89 97 165
Changes in Working Capital -9683 11669 -4015 -10216
Cash From Investing Activities -14717 -13243 -9285 -6647
Capital Expenditures -9407 -5828 -5878 -4693
Other Investing Cash Flow Items, Total -5310 -7415 -3407 -1954
Cash From Financing Activities -10116 -19832 -12589 -20621
Financing Cash Flow Items - - -3393 3393
Total Cash Dividends Paid - -13430 - -18337
Issuance (Retirement) of Stock, Net -9761 -6141 -8823 -5199
Issuance (Retirement) of Debt, Net -355 -261 -373 -478
Foreign Exchange Effects 462 - - -209
Net Change in Cash -15491 8309 6638 2283
Beginning Cash Balance 29883 21835 14936 12653
Ending Cash Balance 14392 30144 21574 14936
Free Cash Flow -13719.25 30870.62 14720 22231.38
Free Cash Flow Growth -144.44 109.72 -33.79 648.8
Free Cash Flow Yield -0.221 1.05 0.873 1.02
* In Millions of DKK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk L
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email